-
Carrot recall: FDA lists more products, grocery stores linked to E. coli outbreak
A recent E. coli outbreak linked to organic, bagged carrots that has sickened nearly 40 people across 18 states has led other popular brands to recall vegetables because of possible contamination, including additional products sold at Whole Foods.
-
New FDA rules for TV drug ads: Simpler language and no distractions
New rules require drugmakers to be clearer about explaining the risks and side effects of prescription drugs.
-
What to know about Robert F. Kennedy Jr., Trump's pick for health secretary
Robert F. Kennedy Jr. has promoted claims about vaccines that contradict the overwhelming consensus of scientists.
-
Brie cheese brand recalled due to potential contamination with listeria
Savencia Cheese USA is recalling several of its soft ripened cheeses after finding that processing equipment at its Lena, Illinois, facility may have been contaminated with listeria, a type of bacteria.
-
FDA proposes ending use of decongestant found in many cold, allergy medicines
The FDA said the proposed order is not final yet, which means companies can still market over-the-counter drugs containing oral phenylephrine for now.
-
FDA recalls antidepressant duloxetine
Potentially harmful levels of a carcinogenic chemical have been found in a widely-used medication.
-
Why do we see prescription drug shortages?
Forty years after the Hatch-Waxman Act, which provided widespread access to affordable generic versions of medications, the market is struggling with persistent shortages brought about partly by low prices.
-
Nearly 2,000 drug plants are overdue for FDA checks after COVID delays, AP finds
U.S. health inspectors are still struggling to address a massive backlog of pharmaceutical plants that went uninspected during disruptions caused by COVID-19. That’s according to an analysis of government data by the Associated Press. The data shows roughly 2,000 drug manufacturing sites around the world have not had a Food and Drug Administration inspection for quality since before the pandemic....
-
Teen vaping hits 10-year low in US, new data show
Youth vaping levels fell to the lowest in a decade this year, according to a new report from the Centers for Disease Control and Prevention and the Food and Drug Administration.
-
FDA rejects psychedelic MDMA as treatment for PTSD, calling for additional study
Federal health officials have declined to approve the psychedelic drug MDMA as a therapy for PTSD. Drugmaker Lykos Therapeutics announced the FDA’s decision on Friday.
-
FDA approves first nasal spray to treat dangerous allergic reactions
U.S. health officials have approved the first nasal spray to treat severe allergic reactions, offering an alternative to injectable products like EpiPen.
-
FDA's ‘hands-off approach' to additives may allow unsafe ingredients in food, experts suggest
A loophole means manufacturers don’t need approval before adding new ingredients, such as natural sweeteners and texture enhancers, to foods, researchers say in an editorial.
-
FDA once again pushes back proposal to ban cancer-linked formaldehyde in hair relaxers
The Food and Drug Administration’s proposal to ban formaldehyde in hair care products has been pushed back once again, and the timeline for its release remains undetermined.
-
FDA OKs first menthol e-cigarettes, citing potential to help adult smokers
Friday’s action is the government’s strongest indication yet that switching to flavored vaping can reduce the harms traditional tobacco smoking.
-
The FDA reverses its ban on Juul e-cigarettes
Juul’s nicotine products have been allowed to stay in stores pending review of its application to sell them.
-
Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates
A first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD was roundly criticized Tuesday — a potentially major setback to psychedelic advocates who hope to win a landmark federal approval and bring the banned drugs into the medical mainstream.
-
Psychedelic drug MDMA faces questions as FDA considers approval for PTSD
Federal health regulators are set to review the first request to approve the mind-altering club drug MDMA as a treatment for PTSD. The Food and Drug Administration posted its review of the drug on Friday, raising questions about its effectiveness and potential risks, including heart problems.
-
Can yogurt reduce the risk of Type 2 diabetes?
The U.S. Food and Drug Administration recently said it’s OK for producers of yogurt to make that claim even though it’s based on limited evidence.
-
Bird flu is spreading to more farm animals. Are milk and eggs safe?
A bird flu outbreak in U.S. dairy cows has spread to more than two dozen herds in eight states. That comes weeks after the nation’s largest egg producer found the virus in its chickens. Health officials continue to stress that the risk to the public is low and that the U.S. food supply remains safe and stable.
-
FDA warns about lead contamination in more cinnamon products in the US
The Food and Drug Administration issued a safety warning Wednesday, saying it identified additional cinnamon products in the United States that are contaminated with lead.